EVAX
Evaxion·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
EVAX fundamentals
Evaxion (EVAX) released its earnings on Nov 6, 2025: revenue was 7.49M (YoY +148.33%), beat estimates; EPS was 0.01 (YoY +125.00%), beat estimates.
Revenue / YoY
7.49M
+148.33%
EPS / YoY
0.01
+125.00%
Report date
Nov 6, 2025
EVAX Earnings Call Summary for Q3,2025
- MSD Deal Boosts Liquidity: $7.5 million option exercise extends cash runway to mid-2027, with potential $592 million in future milestones.
- EVX-01 Clinical Success: 75% objective response rate at two years, validating AI-driven neoantigen vaccine approach.
- Innovative AML Program: EVX-04 targets shared ERV antigens, offering a novel off-the-shelf cancer vaccine strategy.
- New CEO Leadership: Dr. Helen Tayton-Martin's appointment signals strategic focus on partnerships and pipeline advancement.
EPS
Revenue
Revenue & Expenses
EVAX has released its 2025 Q3 earnings report, with revenue of 7.49M, reflecting a YoY change of 148.33%, and net profit of 4.62M, showing a YoY change of 338.66%. The Sankey diagram below clearly presents EVAX's revenue sources and cost distribution.
Key Indicators
Evaxion (EVAX) key financial stats and ratios, covering profitability, financial health, and leverage.
Evaxion (EVAX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Evaxion (EVAX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Evaxion (EVAX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Evaxion (EVAX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Evaxion (EVAX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Evaxion’s earnings call?What guidance did Evaxion's management provide for the next earnings period?Did Evaxion beat or miss consensus estimates last quarter?What factors drove the changes in Evaxion's revenue and profit?What were the key takeaways from Evaxion's earnings call?What does Evaxion do and what are its main business segments?What is Evaxion's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Evaxion year over year?
